IBM, Cisco Systems And Exxon Mobil Continue To Lead The 'Dogs Of The Dow' In March

&l;p&g;&l;img class=&q;dam-image bloomberg size-large wp-image-33923244&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/33923244/960x0.jpg?fit=scale&q; data-height=&q;638&q; data-width=&q;960&q;&g;

The eight &a;ldquo;Dogs of the Dow&a;rdquo; for 2019 had an aggregate year-to-date gain of 10.7% in March up from 8.8% at the end of February led by a gain of 24.6% for Cisco Systems, 24.1% for IBM and 18.5% for Exxon Mobil. The Dow Jones Industrial Average ended March with a year-to-date gain of 11.2% up slightly from 11.1% at the end of February.

&l;p class=&q;tweet_line&q;&g;The Scorecard for the 2019 &a;ldquo;Dogs of the Dow&a;rdquo;&l;/p&g;

&l;img class=&q;size-full wp-image-59717&q; src=&q;http://blogs-images.forbes.com/investor/files/2019/04/DogsMarch2019.jpg?width=960&q; alt=&q;&q; data-height=&q;420&q; data-width=&q;988&q;&g; Dogs of the Dow

&l;strong&g;Cisco Systems (CSCO)&l;/strong&g; ended March with a dividend yield of 2.59% down from 3.32% in December, ranked 15&l;sup&g;th&l;/sup&g;. &l;strong&g;&l;em&g;The stock would not be a member of the Dog pound at today&a;rsquo;s valuation. &l;/em&g;&l;/strong&g;The weekly chart for Cisco is positive but overbought with the stock above its five-week modified moving average of $51.69 and well above its 200-week simple moving average or &a;ldquo;reversion to the mean&a;rdquo; at $35.16. The 12x3x3 weekly slow stochastic reading is projected to rise to 92.91 this week above the 90.00 threshold of so Cisco is an &a;ldquo;inflating parabolic bubble&a;rdquo;. Buy weakness to my semiannual and annual value levels of $41.70 and $39.84, respectively, and reduce holdings on strength to my monthly risky level at $55.58. My quarterly pivot is $52.67.

&l;strong&g;Chevron (CVX)&l;/strong&g; ended March with a dividend yield of 3.93% down from 4.27% in December, ranked 4&l;sup&g;th&l;/sup&g;. The weekly chart for Chevron is positive but overbought with the stock above its five-week MMA at $121.77 and above its 200-week SMA or &a;ldquo;reversion to the mean&a;rdquo; at $107.81. The 12x3x3 weekly slow stochastic reading is above the overbought threshold of 80.00 at 85.61. Buy weakness to my monthly and semiannual value levels of $109.44 and $106.15, respectively, and reduce holdings on strength to my quarterly and annual risky levels at $129.28 and $131.43, respectively.

&l;strong&g;International Business Machines (IBM) &l;/strong&g;ended March with a dividend yield of 4.65% down from 5.71% in December, still ranked 1&l;sup&g;st&l;/sup&g;. The weekly chart for IBM is positive but overbought with the stock above its five-week MMA at $137.81 but below its 200-week SMA or &a;ldquo;reversion to the mean&a;rdquo; at $149.23. The 12x3x3 weekly slow stochastic reading is projected to rise to 93.45 this week as an &a;ldquo;inflating parabolic bubble.&a;rdquo; Buy weakness to my semiannual, monthly and quarterly value levels at $126.75, $123.03 and $113.89, respectively, and reduce holdings on strength to my annual risky level at $166.09.

&l;strong&g;JPMorgan Chase &a;amp; Co (JPM) &l;/strong&g;ended March with a dividend yield of 3.50% up from 3.45% in December, now ranked 5&l;sup&g;th&l;/sup&g;. The weekly chart for our nation&a;rsquo;s largest bank is neutral with the stock above its five-week MMA at $103.04 and above its 200-week SMA or &a;ldquo;reversion to the mean&a;rdquo; at $86.81. The 12x3x3 weekly slow stochastic reading is projected to decline to 55.29 this week. Buy weakness to my monthly value level at $97.40 and reduce holdings strength to my semiannual and quarterly risky levels at $110.75 and $116.81, respectively. My annual pivot remains at $102.64.

&l;strong&g;Coca Cola (KO) &l;/strong&g;ended March with a dividend yield of 3.44% down from 3.46% in December, now ranked 7&l;sup&g;th&l;/sup&g;. The weekly chart for Coke is positive with the stock above its five-week MMA at $46.40 and above its 200-week SMA or &a;ldquo;reversion to the mean&a;rdquo; at $44.10. The 12x3x3 weekly slow stochastic reading is projected to rise to 27.85 this week. Buy weakness to the 200-week SMA at $44.10 and reduce holdings on strength to monthly, quarterly and annual at $47.50, $48.74 and $51.51, respectively. My semiannual pivot at $46.28 is a magnet.

&l;strong&g;Pfizer (PFE) &l;/strong&g;ended March with a dividend yield of 3.44% up from 3.30% in December, now ranked 6&l;sup&g;th&l;/sup&g;. The weekly chart for Pfizer is positive with the stock above its five-week MMA at $42.35. The stock is well above its 200-week SMA or &a;ldquo;reversion to the mean&a;rdquo; at $35.59. The 12x3x3 weekly slow stochastic reading is projected to rise to 56.74 this week. Buy weakness to my semiannual value level at $41.49 and reduce holdings on strength to my monthly and annual risky levels at $46.57 and $48.44, respectively. My quarterly pivot is $43.55.

&l;strong&g;Verizon (VZ) &l;/strong&g;ended March with a dividend yield of 4.12% down from 4.31% in December, ranked 3&l;sup&g;nd&l;/sup&g;. The weekly chart for Verizon is positive with the stock above its five-week MMA at $57.94. The stock is above its 200-week SMA or &a;ldquo;reversion to the mean&a;rdquo; at $50.38. The 12x3x3 weekly slow stochastic reading is projected to rise to 77.71 this week. Buy weakness to my quarterly and semiannual value levels at $56.38 and $55.97, respectively, and reduce holdings on strength to my monthly and annual risky levels at $62.05 and $62.95, respectively.

&l;strong&g;Exxon Mobil (XOM) &l;/strong&g;ended March with a dividend yield of 4.31% down from 5.03% in December, ranked 2&l;sup&g;nd&l;/sup&g;. The weekly chart for Exxon Mobil is positive but overbought with the stock above its five-week MMA at $79.18 and testing its 200-week SMA or &a;ldquo;reversion to the mean&a;rdquo; at $81.66. The 12x3x3 weekly slow stochastic reading is projected to rise to 88.42 this week above the overbought threshold of 80.00. Buy weakness to my monthly, semiannual and quarterly value levels at $75.48, $69.47 and $77.66, respectively, and reduce holdings on strength to my annual risky level at $94.26.&l;/p&g;

Here are the biggest analyst calls of the day: Tesla, O'Reilly, Fox, & more

Here are the biggest calls on Wall Street on Monday.

RBC lowered their price target on Tesla to $210 from $245

RBC sees softer demand expectations and a delivery snag in China.

"Tesla is expected to report 1Q19 deliveries in early April... We revise down our total unit forecast by ~10% owing to meager demand and some M3 delivery issues abroad... We also incorporated lower pricing (and hence margins) on a go forward basis. Our PT moves to $210, reiterate Underperform..."

Read more about this here.

J.P. Morgan initiated Fox as 'overweight'

J.P. Morgan was impressed with the new company's array of businesses.

"We are initiating coverage of FOX Corporation with an Overweight rating and a December 2019 price target of $46... FOXA has an impressive mix of businesses, including strong cable channels driven by live news and sports, as well as a major broadcast network with a leading local TV footprint... We believe FOXA shares will maintain a premium valuation over the average in our large-cap media universe due to its higher growth profile, implying notable upside to shares from the current level..."

J.P. Morgan added O'Reilly Automotive to the analyst 'focus list'

J.P. Morgan said the colder weather in areas of O'Reilly shops will benefit it more than Advance Auto Parts, AutoZone and Genuine Parts as the harsh winter causes more auto repairs.

"Adding ORLY to the JPM Analyst Focus List given favorable three consecutive season setup... We are adding ORLY to the JPM Analyst Focus List as growth idea as we believe ORLY is likely to regain the best comp crown in the group after yielding it to AAP in 2H18... Specific to our analysis, on geographically-weighted basis, after a favorable temperature (-3.6 degrees) and snowfall experience (+143 inches across its footprint) in 2018, ORLY ranked first in terms of summer temperature YOY (+1.6 degrees)... Moreover, the 2019 winter saw temperatures only modestly higher (+0.8 degrees, similar to peers) with snow actually up YOY (+129 inches across markets)..."

Susquehanna upgraded Hibbett Sports to 'positive' from 'neutral'

Susquehanna said the athletic-inspired fashion retailer issued impressive an impressive earnings report.

"Better than expected SSS, operating margin, inventory levels, FY20 outlook, and indications that the City Gear acquisition was a very good idea are proving out have led us to upgrade the stock... Further, strong relationships with major vendors, and initiatives to jumpstart B&M sales are evident... We are raising our FY20/FY21 EPS estimates from $1.76/$1.93 to $1.93/$2.25, and increasing our PT [on HIBB] from $20 to $27..."

Wedbush added Signature Bank to the 'best ideas' list

Wedbush said Signature is one of the better positioned banks to benefit from lower rates.

"We are adding Signature Bank to the Best Ideas List as we believe it is one of the best positioned banks to benefit from the Fed having become more dovish than the market anticipated in its most recent FOMC meeting last week. Furthermore, Trump's nomination of Stephen Moore on Friday to the Fed board could tilt the board to be even more dovish given Moore has publicly criticized Fed chairman Powell's interest rate policy as being too tight. Fed fund futures are now predicting a 58% probability of a rate cut by year-end 2019..."

Bernstein downgraded Texas Instruments & Analog Devices to 'market perform' from 'outperform'

Bernstein is nervous about the set-up into the second half and believes both semiconductor companies are more expensive than others in its coverage universe.

"Overall we are growing increasingly nervous about the set-up for the industry into the 2H (with inventories remaining elevated, expectations higher, and valuations less favorable).. Consequently, after the recent run we are taking the opportunity to move to the sidelines on TXN and ADI (more broadly exposed, and more expensive, in our coverage)... We wouldn't talk anyone out of owning either for the long term (and we remain positively biased on the quality of the business franchises and execution) but given the broader set-up we might prefer to put new money to work in other parts of the space with more valuation support...."

Cramer Remix: You can't invest in Kylie Jenner, but this stock could help

Ulta Beauty CEO Mary Dillon is showing how retail can work and is "crushing" the competition along the way, CNBC's Jim Cramer said Tuesday.

The cosmetics company reported a great quarter last week, including more than 9 percent same-store sales growth and a 14 percent subscriber growth in its rewards program, he said. Ulta Beauty's 31.8 million people on its rewards program also trumps the 16 million on Starbucks' loyalty plan, he said, pointing out that Starbucks has 10 times the number of locations Ulta Beauty has.

"Ulta's rewards program is so persuasive, with various tiers of value that I found myself wondering why don't more retailers adopt this model?" the "Mad Money" host said. "Mary Dillon understands that the future of retail is all about personalization."

Additionally, Ulta is keeping their stores and website fresh, Cramer said. On top of that, the company has a dominant influencer reach on social media, particularly through Kylie Jenner and her line of cosmetics.

"When Kylie Jenner launches a line of cosmetics, making herself the youngest ever, well let's say allegedly, self-made billionaire, you can't invest in her," he said. "But you can invest in Ulta, which has the best chance to replenish a product line that was sold out this quarter."

Who knows how much money the beauty chain could have made if it had enough of Jenner's products in inventory?

Get Cramer's full thoughts here

Making cents of the market Michael Nagle | Bloomberg | Getty Images Pedestrians pass in front of the New York Stock Exchange.

Investors have reason to stay optimistic about the market in the long run if the Federal Reserve continues to hold interest rates and there's hope that a trade deal with China will come through, Cramer said.

The major indexes soared during the session before losing their gains after news broke that China could walk back some concessions. The Dow Jones Industrial Average shed 0.10 percent, the S&P 500 slipped 0.01 percent, and the Nasdaq finished up 0.12 percent.

But Cramer said people are wrong to believe that the market's recent strength "was based on a leap of faith."

"The run this morning had a lot more to do with a leap of taste, meaning money managers were buying the stocks of high-quality companies because their stories are meatier than the average investor may realize, even as they threw away other stocks that need good news on trade to go higher as the session moved on into the late hours," the host said.

Click here for Cramer's full thoughts

Reinvesting in customers Scott Mlyn | CNBC Dheeraj Pandey, CEO, Nutanix

Nutanix, the cloud software for hyper-converged systems, disappointed on latest quarterly earnings report in February and delivered tepid guidance, Cramer said. He checked in with CEO Dheerej Pandey, a day before an analyst call, to find out where the company is going.

"It's not just about communication but it's also about taking a step back and talking about what we did in the last two years ... [when] we said we're going to go after large customers and large deals and we've done a really good job," Pandey said. "What happened last year was that you know there's a flywheel in this business which is if the margins start to go up you take the margins and plow it back into the business [to] get more new customers."

Catch the full interview here

Sailing for selfies Scott Mlyn | CNBC Frank Del Rio, CEO, Norwegian Cruise Line

Millennials make up 25 percent of Norwegian Cruise Line's bookings and the company is putting more accommodations on board its ships to attract the fastest-growing customer base, CEO Frank Del Rio told CNBC.

"We are now building ships with the understanding that Instagram is something to deal with," he said in an interview with Cramer. "We're actually creating Instagram venues so that, when you get the urge, they're going to go there and that's the best publicity [we] can have."

Read more here

Tale of two shipments Anna Moneymaker | Bloomberg | Getty Images Frederick Smith, chairman and chief executive officer of FedEx Corp., speaks during the U.S. Chamber of Commerce Aviation Summit in Washington, D.C., on Thursday, March 7, 2019.

FedEx fell more than 5 percent in after-hours trading after the transports company disappointed on its fiscal third-quarter results Tuesday and cut its full-year earnings guidance.

CEO Frederick Smith called it a "tale of two stories." Despite opening adding more expenses to its budget with "enormous" new hubs in Pennsylvania and Connecticut expanding to 6-day weeks all year, domestic shipments were "pretty good," he said. But international revenues fell short.

"We had anticipated about $6 billion in increased revenues for the fiscal year that ends May 31," Smith told Cramer. "We're going to end up with about $4.5 billion, but we are seeing some green sprouts now in the international side and we're optimistic as we go into FY20."

Watch the full interview here

Cramer's lightning round: This is a winner. Don't let go of this stock

In Cramer's lightning round, the "Mad Money" host sprinted through his reaction to callers' stock picks:

Guardant Health Inc.: "This thing was under priced. I don't know how it became so low, and I loved the fact that they've got some incredible testing. This is actually a winner. I would not let go of this story."

International Business Machines Corp.: "Well I think that the IBM acquisition of Red Hat is actually going to help the company greatly and if Jim Whitehurst stays for the next two years, I think you're going to see the stock up considerably. In the meantime, the yield's four percent and it's got a decent—you know that dividend is not going to climb the way it used to maybe because I spent so much money on Red Hat, but I think the combination is terrific."

Kimberly-Clark Corp.: "Nobody ever got hurt buying Kimberly-Clark. I know it's been down in the dumps of late and [in] the last few years hasn't done as well as Procter [& Gamble]. I do prefer Procter more than Kimberly, but I certainly would not sell Kimberly-Clark here and I do think raw costs are going down."

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com

EURINR is expected to appreciate: Angel Broking

Angel Broking's currency report on EURINR

EURUSD appreciated by 0.7 percent last week while EURINR appreciated by 0.32 percent the same time frame. German data fell short of the market's expectations, denting demand for the shared currency. Meanwhile, CPI from Germany came in at 0.4% for Feb'19 against market expectations of 0.5 percent. The central bank changed its forward guidance on rate hikes, stating that would remain at their present levels 'at least through the end of 2019, and in any case for as long as necessary.

OUTLOOK

EURINR is expected to appreciate in today's session.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More First Published on Mar 18, 2019 12:04 pm

This is the No. 1 issue keeping you from inheriting that windfall

When it comes to passing on wealth to heirs, family dynamics can be the biggest obstacle.

Indeed, nearly 8 out of 10 financial advisors polled by Key Private Bank said that navigating tricky familial relationships is the most difficult part of estate planning.

The bank surveyed about 130 of its own advisors online in December 2018.

"The sensitivities of talking about estate planning often present emotional hurdles to putting a plan in place — especially when multiple marriages and blended families are involved," said Karen Arth, head of trust with Key Private Bank, in a statement.

As blended families become the norm, "the issues of equitable distributions among family members become even more complex," Arth said.

Indeed, the interaction between parents, children, step-parents and step-children can be fraught with tension during the estate-planning process.

This is especially the case when a plan is put into action after a parent or step-parent's death or disability.

But while your family's drama may be getting in the way, there is you can do something about it.

Open secrets lechatnoir | E+ | Getty Images

More than 80 percent of the advisors polled said that few of their clients are "having open conversations about estate plans and wishes with their families."

"Some clients may be hesitant to have a conversation about estate planning with their family members because they fear that sharing their wishes will cause conflict," said Andrea M. Griffiths, national manager of Trust Settlement Administration at Key Private Bank, in a statement.

Talking through your goals and how you'd like to share your wealth with your heirs is only part of the story.

You also have to update your documents to reflect your wishes.

Wills and titles Dottyjo | Getty Images

"It's really important that, with these documents, you're taking care of yourself and your loved ones and your legacy," Arth told CNBC. But just signing a document and moving on isn't enough.

You should look at how your assets are titled and understand who is inheriting your wealth.

"From an estate-planning perspective, there are two main objectives when considering proper asset titling: avoiding probate and control over the disbursement of one's assets," Arth said.

Avoiding probate: Probate is the process that states use to settle the estate of a deceased person. Probate proceedings are made a matter of public record, so there is no family privacy. "It might also be costly and time-consuming, resulting in a delay to beneficiaries in receiving their shares," said Arth.

Disbursements: "Retirement accounts such as IRAs, 401(k)s and pension plans have named beneficiaries. This means that the assets will pass directly outside of the probate process. The same holds true for life insurance and annuity contracts."

It is important to remember that specific beneficiary designations, whether through "payable on death," "transfer on death", etc., will supercede any provisions in a will or trust.

show chapters Where there's a will    12:21 PM ET Tue, 4 Sept 2018 | 03:21

This is why account holders and insurance policy owners must review their beneficiary designations to ensure that the assets will transfer according to their wishes.

Arth gave the example of a client who wanted her assets to go to her grandchildren.

The client had signed a will drafted by an attorney, but didn't have the necessary titling in her grandchildren's names.

The elderly client passed away and her granddaughters got nothing, Arth said. The assets were divided up unequally among her two daughters, who were feuding.

"The woman's legacy was not shared with her granddaughters," she said. "People need to understand what they're doing and the impact."

More from Personal Finance:
Time is running out to switch Medicare Advantage plans
Taxpayers are leaving $1.4 billion in tax refunds on the table
This professor just had $60,000 in student debt cancelled

Traders Buy Shares of Booking (BKNG) on Weakness

Investors bought shares of Booking Holdings Inc. (NASDAQ:BKNG) on weakness during trading hours on Thursday. $251.19 million flowed into the stock on the tick-up and $191.74 million flowed out of the stock on the tick-down, for a money net flow of $59.45 million into the stock. Of all stocks tracked, Booking had the 17th highest net in-flow for the day. Booking traded down ($16.83) for the day and closed at $1,743.88

BKNG has been the topic of several recent research reports. Bank of America reaffirmed a “buy” rating and set a $2,400.00 target price (up previously from $2,300.00) on shares of Booking in a research note on Tuesday, February 26th. Morgan Stanley cut shares of Booking from an “overweight” rating to an “equal weight” rating and lowered their target price for the stock from $2,100.00 to $2,050.00 in a research note on Wednesday, January 9th. Deutsche Bank raised shares of Booking from a “hold” rating to a “buy” rating and lifted their target price for the stock from $2,150.00 to $2,370.00 in a research note on Tuesday, February 5th. SunTrust Banks reaffirmed a “buy” rating and set a $2,150.00 target price on shares of Booking in a research note on Thursday, February 28th. Finally, Zacks Investment Research cut shares of Booking from a “buy” rating to a “hold” rating in a research note on Friday, January 11th. One analyst has rated the stock with a sell rating, twelve have assigned a hold rating and fifteen have issued a buy rating to the company. Booking presently has a consensus rating of “Buy” and a consensus price target of $2,157.70.

Get Booking alerts:

The company has a current ratio of 2.36, a quick ratio of 2.36 and a debt-to-equity ratio of 1.12. The stock has a market cap of $78.14 billion, a price-to-earnings ratio of 18.83, a PEG ratio of 1.33 and a beta of 1.03.

Booking (NASDAQ:BKNG) last announced its quarterly earnings results on Wednesday, February 27th. The business services provider reported $22.49 earnings per share for the quarter, beating the consensus estimate of $19.39 by $3.10. The firm had revenue of $3.21 billion for the quarter, compared to analysts’ expectations of $3.23 billion. Booking had a net margin of 27.52% and a return on equity of 44.63%. The company’s revenue was up 14.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $16.86 EPS. As a group, research analysts anticipate that Booking Holdings Inc. will post 101.74 earnings per share for the current year.

In related news, CEO Gillian Tans sold 294 shares of the business’s stock in a transaction dated Monday, December 17th. The shares were sold at an average price of $1,796.66, for a total value of $528,218.04. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Jeffrey E. Epstein sold 250 shares of the business’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $1,715.00, for a total transaction of $428,750.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 838 shares of company stock worth $1,455,298. Corporate insiders own 0.24% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the stock. Moody National Bank Trust Division purchased a new stake in Booking in the 4th quarter valued at about $53,000. Next Capital Management LLC purchased a new stake in Booking in the 4th quarter valued at about $64,000. Lake Point Wealth Management purchased a new stake in Booking in the 4th quarter valued at about $64,000. Financial Gravity Companies Inc. purchased a new stake in Booking in the 4th quarter valued at about $72,000. Finally, Athena Capital Advisors LLC purchased a new stake in Booking in the 4th quarter valued at about $74,000. Hedge funds and other institutional investors own 88.64% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Traders Buy Shares of Booking (BKNG) on Weakness” was reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be viewed at https://www.tickerreport.com/banking-finance/4221819/traders-buy-shares-of-booking-bkng-on-weakness.html.

Booking Company Profile (NASDAQ:BKNG)

Booking Holdings Inc, formerly The Priceline Group Inc, is a provider of travel and restaurant online reservation and related services. The Company, through its online travel companies (OTCs), connects consumers wishing to make travel reservations with providers of travel services across the world. It offers consumers an array of accommodation reservations (including hotels, bed and breakfasts, hostels, apartments, vacation rentals and other properties) through its Booking.com, priceline.com and agoda.com brands.

Read More: How to Use a Moving Average for Trading 

Fire Warren Buffett? Investors obsessed with quarterly performance would

If Warren Buffett wasn't the head of Berskshire Hathaway and instead worked as a financial advisor for investors, he'd probably have a tough time holding a job these days.

That's because the man known as one of the greatest investors of all-time often underperforms the market, according to an analysis by Michael Crook, head of Americas investment strategy at UBS.

Crook this week updated a chart he first presented in 2015 that showed over daily, monthly and even on a five-year basis, Buffett's Nebraska-based conglomerate often falls short of the S&P 500.

Buffett frequency of outperformance

The point, of course, isn't that investors should shun Buffett. Over time, the results more than justify the patience. But the question is whether in the current climate of short-termism and the demand for immediate results Buffett would last in the business if he didn't already have his reputation.

As Crook wrote:

The high long-term returns achieved by Berkshire Hathaway required patience through extended underperformance. My conclusion: Since most investors would fire Warren Buffett, they are also probably too quick to sell something out of a portfolio when it hasn't worked over 1-5 years (e.g. specific stocks, asset classes, and/or managers).

Buffett's outperformance over the entire period: 350 percent.

Buffett himself has long preached about the importance of long-range thinking. He doesn't dwell on his company's short-term performance, and he and J.P. Morgan Chase CEO Jamie Dimon recently floated the idea of ending the corporate practice of providing quarterly guidance to investors.

But that might not matter to some of today's investors.

"I'm actually seeing the same short-termism now in retail clients, and it's happening more often because people look at the last 10 years and say, 'You know, I thought I would have done better,'" said Mitch Goldberg, president of ClientFirst Strategy. "They forget that they're either moderate-risk investors or growth and income-based investors. They've been investing within their risk tolerance, and a lot of people are thinking, 'I don't need to worry about my risk tolerance anymore.'"

That could be happening at exactly the wrong time.

The market is getting trickier, with volatility increasing as the dynamics that have driven the decade-long bull changing. After a protracted span of approaching the market cautiously, the desire for investors to escape the shackles of risk-aversion is classic late-cycle behavior.

"I speak to financial advisors all the time. Whenever we see each other, we all feel the investing public has forgotten about the concept of risk" Goldberg said. "Investors were overly focused on risk from 2009 to 2016. And now their attitude toward risk has gone completely the other way. This is very emblematic of end-of-bull-market performance."

Cannabis stocks rally after NJ governor, lawmakers unveil plan for legal weed

Shares of major cannabis companies rallied Tuesday after New Jersey politicians outlined plans to legalize the adult use of recreational marijuana in the state.

Several New Jersey legislators joined Democratic Governor Phil Murphy in announcing Tuesday a bill that would allow adult-use marijuana in the Garden State. The legislation would also allow municipalities that are home to a cultivator or manufacturer to collect the revenue from a 2 percent tax on the product within their jurisdiction.

"Legalizing adult-use marijuana is a monumental step to reducing disparities in our criminal justice system," Murphy said in a press release. "After months of hard work and thoughtful negotiations, I'm thrilled to announce an agreement with my partners in the Legislature on the broad outlines of adult-use marijuana legislation."

If the bill is passed and signed into law, the New Jersey adult-use marijuana market would be governed by a Cannabis Regulatory Commission, composed of five members appointed by the governor. The commission will be tasked with promoting regulations to govern the industry and will oversee applications for licensing.

Growing cannabis also would be subject to an excise tax of $42 per ounce and municipalities that are home to a cultivator or manufacturer will receive the revenue from a 2 percent tax. Cities and townships home to a retailer would receive the revenue from a 3 percent tax on products sold.

Many of the largest cannabis companies in the world rallied Tuesday following the announcement from the Democratic governor, including a number of Canadian growers.

Cronos Group rallied 4.5 percent, Canopy Growth gained 3.7 percent, Tilray added 3.4 percent and Aurora rose 2.6 percent. Nine of the top 10 holdings of the $1.1 billion ETFMG Alternative Harvest ETF — a fund that tracks the equity performance of many companies that legally cultivate cannabis — gained in midday trading Tuesday.

Some U.S.-based companies in the cannabis space also rose Tuesday. New York-based Acreage Holdings, where former U.S. House of Representatives Speaker John Boehner serves as a director, gained 2.7 percent. Meanwhile, Green Thumb Industries, an investment of billionaire Leon Cooperman's, rose 5.6 percent. Both stocks trade on exchanges in Canada.

Certain provisions in the bill also establish an "expedited expungement process" for individuals convicted of low-level marijuana offenses. The bill would include a virtual process that would automatically prevent certain marijuana offenses from being taken into account in certain areas such as education, housing, and occupational licensing.

Adam Jeffery | CNBC Kevin Murphy, CEO of Acreage Holdings.

The lawmakers also said the legislation includes "a number of provisions" designed to guarantee diverse participation in the burgeoning industry for minorites and women-owned businesses. Some states that have moved to legalize recreational use, like Massachusetts, have struggled to broaden participation in the new market to black and Latino entrepreneurs.

Marijuana remains illegal on a federal level in the United States, but 10 states and the District of Columbia have allowed its use for recreational purposes. Michigan in November became one of the latest states to OK recreational marijuana.

5 of the Best Stocks Under $10 for 2019

At Zacks, we try to avoid labeling stocks as “cheap” or “expensive.” Instead, we opt to look beyond a stock’s face value, and our system puts an emphasis on earnings estimate revisions to find stocks that will hopefully be winners for investors.

With that said, low-priced stocks can still be attractive to investors as they present the chance to take a larger position in a company, which they might not be able to in higher-priced stocks. When searching for these low-priced stocks, we still look for similar trends in growth, value, and momentum. Then we apply the Zacks Rank to properly analyze the potential that these companies have.

Today we’ve highlighted five stocks that are currently trading for under $10 per share. All of these stocks currently sport a Zacks Rank #2 (Buy) or better, and the selected companies are showing signs of outpacing the market throughout 2019.

Check out these five great stocks under $10 for 2019:

1. Glu Mobile Inc. (GLUU )

Prior Close: $9.04

Glu Mobile is a global developer and publisher of free-to-play mobile video games, such as MLB Tap Baseball 2018, Deer Hunter, Kim Kardashian Hollywood, and more. The firm saw its 2018 revenue surge 28% to reach $366.6 million. GLUU stock has climbed 12% to start the year and it has some new games entering beta, including a Disney/Pixar (DIS ) title, that could help the company expand this year.

Glu Mobile’s adjusted current-quarter EPS share figure is projected to climb 67%, based on our current Zacks Consensus Estimate. Meanwhile, the company’s full-year 2019 earnings are projected to skyrocket 230% on the back of 16% revenue growth. The company’s positive earnings estimate revision activity helps it earn a Zacks rank Zacks Rank #2 (Buy). Plus, investors should remember that mobile gaming is on the rise as part of the broader video game market expansion.

2. Digital Turbine, Inc. (APPS )

Prior Close: $3.05 USD

Digital Turbine is coming off a fiscal third quarter that saw it top earnings and revenue estimates. The company operates in our Internet – Software industry and its business tries to connect OEMs, mobile operators, and publishers with advertisers and app developers. APPS’ positive earnings revision activity helps it earn a #1 (Strong Buy) rank.

The Austin, Texas-based company is expected to swing from an adjusted loss of $0.01 per share in the year-ago period to earnings of $0.02 a share in the current quarter, for a 300% expansion. This impressive bottom-line growth is projected to continue in the following quarter and the coming fiscal year. Meanwhile, Digital Turbine’s bottom-line expansion is expected to be supported by 26.7% revenue growth in Q4.

3. Trivago (TRVG )

Prior Close: $5.41 USD

Trivago is a German-based hotel and accommodation search platform that closed 2018 with the ability to connect customers in over 190 countries to more than three million hotels and alternative accommodations, such as private apartments. Shares of TRVG have tumbled 37% over the last year from almost $9 a share to below $6. With that said, the company operates in a high-margin business and Trivago saw its profits jump in the fourth quarter, while the company’s consolidated revenue per qualified referral jumped 13%.

Peeking ahead, our Zacks Consensus Estimate calls for the company’s adjusted Q1 fiscal 2019 earnings to soar 129%. This bottom-line growth is expected to continue for the full year with 2019’s earnings projected to skyrocket over 214%. On top of that, Trivago’s 2020 revenue is projected to climb 7.8% above our current year estimate that calls for a 2.4% decline. Trivago is currently a Zacks Rank #2 (Buy) based, in part, on its positive earnings estimate revision activity.

4. Radiant Logistics Inc. (RLGT )

Prior Close: $6.13 USD

Radiant Logistics is a global transportation and supply chain management firm that operates everything from retail sector white-glove delivery services to heavy machinery transportation. Shares of RLGT have soared over 44% so far this year and the company is part of the Transportation – Air Freight and Cargo industry that currently rests in the top 7% of our 256 Zacks industries.

Radiant is a Zacks Rank #1 (Strong Buy) right now that boasts “A” grades for Value, Growth, and Momentum in our Style Scores system. Plus, the company is trading at a respectable P/E of 12.5, which comes in just above its industry’s 11.7X average. The company is also expected to see its adjusted current-year earnings soar over 62% on the back of 13.6% revenue growth.

5. Telenav, Inc. (TNAV )

Prior Close: $5.98 USD

Telenav provides connected car and location-based services and saw 1.3 million vehicles equipped with its technology enter the global market last quarter. The company works with companies such as General Motors (GM ) and Toyota (TM ) . Investors might also be happy to note that Telenav just recently announced a partnership with Amazon (AMZN ) to bring its widely popular Alexa voice assistant technology to Telenav’s navigation system offerings.

TNAV stock has soared 47% in 2019 and the company’s positive earnings estimate revision activity helps it sport a Zacks Rank #2 (Buy). Telenav is expected to see its current-quarter earnings surge over 78% on the back of a 269% jump in revenue. Meanwhile, the connected car tech firm’s full-year EPS is projected to surge roughly 76%, with its top-line expected to soar 101% to reach $214.17 million. The company also rocks an “A” grade for Growth and has a P/S ratio of 1.87, which falls below some of its peers.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>

Q2 2020 Earnings Forecast for American Eagle Outfitters (AEO) Issued By B. Riley

American Eagle Outfitters (NYSE:AEO) – Equities researchers at B. Riley decreased their Q2 2020 earnings per share (EPS) estimates for shares of American Eagle Outfitters in a report released on Thursday, March 7th. B. Riley analyst S. Anderson now anticipates that the apparel retailer will post earnings per share of $0.34 for the quarter, down from their previous estimate of $0.35. B. Riley also issued estimates for American Eagle Outfitters’ Q3 2020 earnings at $0.54 EPS, Q4 2020 earnings at $0.51 EPS and FY2021 earnings at $1.75 EPS.

Get American Eagle Outfitters alerts:

AEO has been the subject of several other reports. Zacks Investment Research raised American Eagle Outfitters from a “hold” rating to a “buy” rating and set a $21.00 price objective for the company in a research note on Thursday, December 13th. Jefferies Financial Group set a $28.00 price objective on American Eagle Outfitters and gave the stock a “buy” rating in a research report on Thursday. Wedbush set a $25.00 price target on American Eagle Outfitters and gave the stock a “buy” rating in a research report on Wednesday, December 12th. Deutsche Bank set a $23.00 price objective on American Eagle Outfitters and gave the company a “buy” rating in a report on Wednesday, December 12th. Finally, Loop Capital set a $27.00 price target on American Eagle Outfitters and gave the company a “buy” rating in a research note on Tuesday, December 11th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and nine have issued a buy rating to the company. American Eagle Outfitters has an average rating of “Buy” and an average target price of $24.62.

American Eagle Outfitters stock opened at $20.18 on Friday. The firm has a market cap of $3.56 billion, a P/E ratio of 13.40, a PEG ratio of 1.20 and a beta of 0.82. American Eagle Outfitters has a one year low of $17.00 and a one year high of $29.88.

American Eagle Outfitters (NYSE:AEO) last posted its earnings results on Wednesday, March 6th. The apparel retailer reported $0.43 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.42 by $0.01. American Eagle Outfitters had a return on equity of 21.28% and a net margin of 6.96%. The firm had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.26 billion. During the same period in the previous year, the firm earned $0.44 earnings per share. The business’s revenue was up 1.2% compared to the same quarter last year.

In related news, EVP Andrew J. Mclean sold 14,984 shares of the stock in a transaction that occurred on Friday, December 14th. The shares were sold at an average price of $18.26, for a total transaction of $273,607.84. Following the completion of the sale, the executive vice president now directly owns 14,984 shares of the company’s stock, valued at $273,607.84. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 6.30% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in the business. Cornerstone Wealth Management LLC bought a new stake in shares of American Eagle Outfitters during the 3rd quarter worth $273,000. Russell Investments Group Ltd. raised its stake in shares of American Eagle Outfitters by 53.4% in the 3rd quarter. Russell Investments Group Ltd. now owns 124,976 shares of the apparel retailer’s stock valued at $3,103,000 after buying an additional 43,531 shares in the last quarter. Assenagon Asset Management S.A. acquired a new stake in shares of American Eagle Outfitters during the 3rd quarter worth about $1,504,000. Arizona State Retirement System increased its position in shares of American Eagle Outfitters by 2.7% during the 3rd quarter. Arizona State Retirement System now owns 119,642 shares of the apparel retailer’s stock worth $2,971,000 after purchasing an additional 3,154 shares in the last quarter. Finally, State Board of Administration of Florida Retirement System increased its position in American Eagle Outfitters by 10.2% in the 3rd quarter. State Board of Administration of Florida Retirement System now owns 127,781 shares of the apparel retailer’s stock valued at $3,173,000 after acquiring an additional 11,859 shares in the last quarter. Hedge funds and other institutional investors own 88.64% of the company’s stock.

About American Eagle Outfitters

American Eagle Outfitters, Inc operates as a specialty retailer that provides clothing, accessories, and personal care products under the American Eagle Outfitters and Aerie brands. The company also provides jeans, and other apparel and accessories for men and women; and intimates, activewear, and swim collections, as well as personal care products for women.

Recommended Story: Consumer behavior in bull markets

Care.com (CRCM) Trading Down 5.7%

Care.com Inc (NYSE:CRCM) fell 5.7% during mid-day trading on Thursday . The company traded as low as $21.00 and last traded at $22.80. 699,239 shares were traded during trading, an increase of 54% from the average session volume of 454,439 shares. The stock had previously closed at $24.17.

A number of research firms recently issued reports on CRCM. Roth Capital upped their price target on shares of Care.com from $24.00 to $30.00 and gave the company a “buy” rating in a research note on Thursday, February 14th. BTIG Research upped their price target on shares of Care.com to $26.00 and gave the company a “buy” rating in a research note on Friday, January 18th. Zacks Investment Research raised shares of Care.com from a “hold” rating to a “buy” rating and set a $23.00 price target on the stock in a research note on Monday, January 7th. Finally, ValuEngine raised shares of Care.com from a “buy” rating to a “strong-buy” rating in a research note on Friday, December 21st. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. Care.com has an average rating of “Buy” and a consensus price target of $24.60.

Get Care.com alerts:

The company has a market cap of $801.60 million, a PE ratio of 109.61, a price-to-earnings-growth ratio of 5.80 and a beta of 1.09.

Care.com (NYSE:CRCM) last released its quarterly earnings results on Thursday, March 7th. The information services provider reported $0.26 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.21 by $0.05. The company had revenue of $49.80 million for the quarter, compared to the consensus estimate of $49.95 million. Care.com had a net margin of 6.58% and a return on equity of 13.15%. Care.com’s revenue was up 12.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.32 earnings per share. Equities analysts expect that Care.com Inc will post 0.26 EPS for the current year.

In other Care.com news, insider Sheila Lirio Marcelo sold 30,000 shares of the business’s stock in a transaction on Thursday, December 27th. The shares were sold at an average price of $18.99, for a total transaction of $569,700.00. Following the transaction, the insider now owns 1,084,153 shares in the company, valued at $20,588,065.47. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider David Krupinski sold 3,510 shares of the business’s stock in a transaction on Tuesday, December 11th. The shares were sold at an average price of $16.85, for a total transaction of $59,143.50. Following the transaction, the insider now owns 139,462 shares in the company, valued at approximately $2,349,934.70. The disclosure for this sale can be found here. Insiders have sold 164,094 shares of company stock worth $3,241,316 in the last quarter. Company insiders own 30.90% of the company’s stock.

Hedge funds have recently bought and sold shares of the business. Oppenheimer Asset Management Inc. bought a new position in Care.com during the fourth quarter valued at $31,000. Zurcher Kantonalbank Zurich Cantonalbank bought a new position in shares of Care.com in the fourth quarter worth about $43,000. Great West Life Assurance Co. Can bought a new position in shares of Care.com in the fourth quarter worth about $96,000. Metropolitan Life Insurance Co. NY grew its holdings in shares of Care.com by 263.6% in the fourth quarter. Metropolitan Life Insurance Co. NY now owns 5,337 shares of the information services provider’s stock worth $103,000 after purchasing an additional 3,869 shares during the last quarter. Finally, Menta Capital LLC bought a new position in shares of Care.com in the fourth quarter worth about $230,000. Institutional investors and hedge funds own 76.37% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was originally published by Ticker Report and is the property of of Ticker Report. If you are reading this news story on another domain, it was stolen and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://www.tickerreport.com/banking-finance/4204820/care-com-crcm-trading-down-5-7.html.

Care.com Company Profile (NYSE:CRCM)

Care.com, Inc operates an online marketplace for finding and managing family care in the United States and internationally. The company helps families to address their lifecycle of care needs, including child care, senior care, and special needs care, as well as other non-medical family care needs, such as pet care, tutoring, and housekeeping; and enables caregivers to find full-time and part-time employment opportunities.

Featured Article: Why is cost of goods sold important?

Commercial Metals (CMC) Holdings Lowered by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. trimmed its stake in shares of Commercial Metals (NYSE:CMC) by 6.4% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 152,016 shares of the basic materials company’s stock after selling 10,450 shares during the period. PNC Financial Services Group Inc.’s holdings in Commercial Metals were worth $2,435,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in CMC. SignalPoint Asset Management LLC raised its holdings in shares of Commercial Metals by 3.5% in the 4th quarter. SignalPoint Asset Management LLC now owns 25,331 shares of the basic materials company’s stock worth $406,000 after purchasing an additional 852 shares in the last quarter. Retirement Systems of Alabama raised its holdings in shares of Commercial Metals by 0.9% in the 4th quarter. Retirement Systems of Alabama now owns 152,509 shares of the basic materials company’s stock worth $2,443,000 after purchasing an additional 1,290 shares in the last quarter. Bank of Montreal Can raised its holdings in shares of Commercial Metals by 1.4% in the 4th quarter. Bank of Montreal Can now owns 92,612 shares of the basic materials company’s stock worth $1,483,000 after purchasing an additional 1,290 shares in the last quarter. Arizona State Retirement System raised its holdings in shares of Commercial Metals by 1.6% in the 4th quarter. Arizona State Retirement System now owns 84,428 shares of the basic materials company’s stock worth $1,353,000 after purchasing an additional 1,342 shares in the last quarter. Finally, ClariVest Asset Management LLC raised its holdings in shares of Commercial Metals by 0.8% in the 4th quarter. ClariVest Asset Management LLC now owns 203,200 shares of the basic materials company’s stock worth $3,255,000 after purchasing an additional 1,700 shares in the last quarter. Institutional investors own 87.45% of the company’s stock.

Get Commercial Metals alerts:

CMC has been the topic of several analyst reports. Goldman Sachs Group raised shares of Commercial Metals from a “neutral” rating to a “buy” rating and set a $21.00 target price on the stock in a research report on Monday, January 14th. ValuEngine downgraded shares of Commercial Metals from a “sell” rating to a “strong sell” rating in a research report on Wednesday, January 9th. Zacks Investment Research raised shares of Commercial Metals from a “hold” rating to a “strong-buy” rating and set a $18.00 target price on the stock in a research report on Wednesday, January 2nd. Seaport Global Securities reissued a “hold” rating on shares of Commercial Metals in a research report on Tuesday, January 8th. Finally, Citigroup set a $18.00 target price on shares of Commercial Metals and gave the stock a “hold” rating in a research report on Tuesday, January 8th. Two research analysts have rated the stock with a sell rating, four have issued a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. Commercial Metals presently has a consensus rating of “Hold” and a consensus price target of $21.11.

Commercial Metals stock opened at $15.65 on Friday. The company has a market capitalization of $2.00 billion, a PE ratio of 10.50 and a beta of 1.32. The company has a current ratio of 2.68, a quick ratio of 1.58 and a debt-to-equity ratio of 0.88. Commercial Metals has a fifty-two week low of $15.23 and a fifty-two week high of $26.59.

Commercial Metals (NYSE:CMC) last released its earnings results on Monday, January 7th. The basic materials company reported $0.35 earnings per share for the quarter, hitting the consensus estimate of $0.35. The business had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.28 billion. Commercial Metals had a net margin of 2.51% and a return on equity of 12.32%. The firm’s quarterly revenue was up 18.7% compared to the same quarter last year. During the same period last year, the firm posted $0.31 earnings per share. On average, equities research analysts predict that Commercial Metals will post 1.86 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Commercial Metals (CMC) Holdings Lowered by PNC Financial Services Group Inc.” was first published by Ticker Report and is the property of of Ticker Report. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/4208274/commercial-metals-cmc-holdings-lowered-by-pnc-financial-services-group-inc.html.

Commercial Metals Company Profile

Commercial Metals Company manufactures, recycles, and markets steel and metal products, and related materials and services in the United States and internationally. It operates through four segments: Americas Recycling, Americas Mills, Americas Fabrication, and International Mill. The Americas Recycling segment processes and sells scrap metals to steel mills and foundries, aluminum sheet and ingot manufacturers, brass and bronze ingot makers, copper refineries and mills, secondary lead smelters, specialty steel mills, high temperature alloy manufacturers, and other consumers.

See Also: Systematic Risk and Investors

Want to see what other hedge funds are holding CMC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Commercial Metals (NYSE:CMC).

Comparing Irhythm Technologies (IRTC) and Boston Scientific (BSX)

Boston Scientific (NYSE:BSX) and Irhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

Analyst Ratings

Get Boston Scientific alerts:

This is a summary of current ratings and recommmendations for Boston Scientific and Irhythm Technologies, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	0	2	21	2	3.00
Irhythm Technologies	0	4	5	0	2.56

Boston Scientific presently has a consensus target price of $40.80, suggesting a potential upside of 2.56%. Irhythm Technologies has a consensus target price of $101.14, suggesting a potential upside of 10.43%. Given Irhythm Technologies’ higher possible upside, analysts clearly believe Irhythm Technologies is more favorable than Boston Scientific.

Valuation and Earnings

This table compares Boston Scientific and Irhythm Technologies’ revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$9.82 billion	5.61	$1.67 billion	$1.47	27.06
Irhythm Technologies	$147.29 million	15.04	-$48.28 million	($1.89)	-48.46

Boston Scientific has higher revenue and earnings than Irhythm Technologies. Irhythm Technologies is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Boston Scientific has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500. Comparatively, Irhythm Technologies has a beta of 1.77, meaning that its share price is 77% more volatile than the S&P 500.

Profitability

This table compares Boston Scientific and Irhythm Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Boston Scientific	17.01%	25.92%	10.27%
Irhythm Technologies	-32.78%	-66.24%	-37.49%

Institutional and Insider Ownership

91.3% of Boston Scientific shares are held by institutional investors. Comparatively, 99.0% of Irhythm Technologies shares are held by institutional investors. 0.7% of Boston Scientific shares are held by company insiders. Comparatively, 5.1% of Irhythm Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Boston Scientific beats Irhythm Technologies on 10 of the 15 factors compared between the two stocks.

Boston Scientific Company Profile

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions therapy products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels; and structural heart therapy systems. It also provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy systems, wires, and stents to treat venous diseases; and peripheral embolization devices, microcatheters, and drainage catheters to treat various cancers. In addition, the company offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to treat abnormalities; remote patient management system; implantable cardiac resynchronization therapy pacemaker systems; and medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, mapping system, and other accessories. Further, it provides products to diagnose and treat diseases of the gastrointestinal and pulmonary conditions; devices to diagnose, treat, and palliate pulmonary diseases within the airway and lungs; and products to treat various urological and pelvic conditions; deep brain stimulation systems for the treatment of parkinson's disease, tremor, and intractable primary and secondary dystonia; and spinal cord stimulator systems for the management of chronic pain. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.

Irhythm Technologies Company Profile

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. Its Zio XT monitor, a single-use, wire-free, and wearable patch-based biosensor, records patient's heartbeats and ECG data. The company was founded in 2006 and is headquartered in San Francisco, California.

Hot Clean Energy Stocks For 2019

tags:RGS,SEM,ING,LFUS, &l;p&g;&l;img class=&q;dam-image bloomberg size-large wp-image-41903517&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/41903517/960x0.jpg?fit=scale&q; data-height=&q;1390&q; data-width=&q;960&q;&g; A rainbow arcs over wind turbines at a wind farm in Scotland. Mike Wilkinson/Bloomberg

As the amount of renewable energy in global electricity networks continues to surge, a new question arises &a;ndash; when will renewables become the dominant source of energy?

A new report, the &l;a href=&q;https://www.lr.org/techradar&q; target=&q;_blank&q;&g;Lloyd&a;rsquo;s Register 2018 Technology Radar&l;/a&g;, examines this issue and also looks at which technologies are likely to have the biggest impact in different countries and what are the key drivers and barriers to success.

A survey of 800 key industry figures found that China would be the first country to achieve grid parity, in 2022, followed by Spain and the United Arab Emirates two years later in 2024. This is the same year that Germany and the UK are expected to see grid parity for wind power, followed a year later by Denmark and the USA. The International Renewable Energy Agency (IRENA) &l;a href=&q;http://www.irena.org/newsroom/pressreleases/2018/Jan/Onshore-Wind-Power-Now-as-Affordable-as-Any-Other-Source&q; target=&q;_blank&q;&g;said recently&l;/a&g; that clean energy sources will be cheaper than fossil fuels by 2020.

Hot Clean Energy Stocks For 2019: Regis Corporation(RGS)

Advisors' Opinion:

• [By Stephan Byrd]

  Shares of Regis Co. (NYSE:RGS) have been given an average rating of “Buy” by the six ratings firms that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $18.00.

• [By Motley Fool Transcribing]

  Regis (NYSE:RGS) Q4 2018 Earnings Conference CallAug. 21, 2018 10:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Dan Caplinger]

  The stock market continued moving up on Tuesday, with the S&P 500 hitting a new high at points during the session before pulling back slightly. Even though the Dow Jones Industrial Average is still well short of its record levels, market participants were pleased to see extremely strong sentiment from investors, especially among stocks of smaller companies. With the current bull market being well into its 10th year, many skeptics have looked for signs of eroding confidence, but those that have appeared recently haven't had any lasting downward impact on stocks. Good news from several companies helped contribute to the positive mood on Wall Street. Cronos Group (NASDAQ:CRON), Medtronic (NYSE:MDT), and Regis (NYSE:RGS) were among the best performers on the day. Here's why they did so well.

• [By Shane Hupp]

  Carriage Services (NYSE: CSV) and Regis (NYSE:RGS) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation and institutional ownership.

• [By Max Byerly]

  JPMorgan Chase & Co. reduced its position in shares of Regis Co. (NYSE:RGS) by 4.0% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,065,983 shares of the company’s stock after selling 44,497 shares during the quarter. JPMorgan Chase & Co. owned about 2.31% of Regis worth $16,128,000 as of its most recent SEC filing.

Hot Clean Energy Stocks For 2019: Select Medical Holdings Corporation(SEM)

Advisors' Opinion:

• [By ]

  Cramer was bearish on Oclaro (OCLR) , Stratasys (SSYS) , Washington Prime Group (WPG) and Select Medical Holdings (SEM) .

  No-Huddle Offense 

  In his "No-Huddle Offense" segment, Cramer proclaimed that it's a fallacy to think that a low price/earnings multiple always means a stock is too cheap. Sometimes, the earnings estimates are simply too high.

• [By Ethan Ryder]

  Select Medical Holdings Co. (NYSE:SEM) insider Scott A. Romberger sold 5,000 shares of Select Medical stock in a transaction dated Monday, June 11th. The shares were sold at an average price of $18.63, for a total transaction of $93,150.00. Following the completion of the transaction, the insider now directly owns 158,485 shares of the company’s stock, valued at $2,952,575.55. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

• [By Logan Wallace]

  Select Medical Holdings Co. (NYSE:SEM) has received a consensus recommendation of “Hold” from the seven research firms that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and one has given a buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $18.50.

• [By Max Byerly]

  Wells Fargo & Company MN boosted its holdings in shares of Select Medical Holdings Co. (NYSE:SEM) by 6.5% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 229,531 shares of the health services provider’s stock after purchasing an additional 14,026 shares during the quarter. Wells Fargo & Company MN’s holdings in Select Medical were worth $3,960,000 as of its most recent SEC filing.

• [By Stephan Byrd]

  Strs Ohio boosted its position in Select Medical Holdings Co. (NYSE:SEM) by 5.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 67,500 shares of the health services provider’s stock after buying an additional 3,300 shares during the quarter. Strs Ohio owned 0.05% of Select Medical worth $1,225,000 at the end of the most recent quarter.

Hot Clean Energy Stocks For 2019: ING Group, N.V.(ING)

Advisors' Opinion:

• [By Joseph Griffin]

  Banco Macro SA ADR Class B (NYSE: BMA) and ING Groep (NYSE:ING) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, analyst recommendations and institutional ownership.

• [By Stephan Byrd]

  ING Groep (NYSE: ING) and OVERSEA-CHINESE/ADR (OTCMKTS:OVCHY) are both large-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability and risk.

• [By Stephan Byrd]

  ING Groep (NYSE: ING) and GRUPO AVAL ACCI/S (NYSE:AVAL) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings.

• [By Joseph Griffin]

  Iungo (CURRENCY:ING) traded down 8.3% against the dollar during the twenty-four hour period ending at 10:00 AM Eastern on June 10th. Iungo has a market capitalization of $2.67 million and approximately $190,723.00 worth of Iungo was traded on exchanges in the last day. One Iungo token can now be purchased for about $0.0667 or 0.00000916 BTC on popular cryptocurrency exchanges including YoBit, IDEX and Kucoin. Over the last week, Iungo has traded 17.7% lower against the dollar.

Hot Clean Energy Stocks For 2019: Littelfuse Inc.(LFUS)

Advisors' Opinion:

• [By Ethan Ryder]

  Littelfuse, Inc. (NASDAQ:LFUS) SVP Matthew Cole sold 150 shares of the business’s stock in a transaction dated Wednesday, August 8th. The shares were sold at an average price of $227.26, for a total transaction of $34,089.00. Following the transaction, the senior vice president now directly owns 4,163 shares of the company’s stock, valued at $946,083.38. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

• [By Ethan Ryder]

  BidaskClub upgraded shares of Littelfuse (NASDAQ:LFUS) from a sell rating to a hold rating in a research note published on Friday morning.

  Several other equities analysts have also commented on LFUS. ValuEngine raised Littelfuse from a hold rating to a buy rating in a report on Thursday, May 3rd. Barrington Research reissued a hold rating on shares of Littelfuse in a report on Tuesday, May 1st. Finally, Zacks Investment Research lowered Littelfuse from a buy rating to a hold rating in a report on Wednesday, April 4th. Six equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Littelfuse has a consensus rating of Hold and a consensus price target of $212.75.

• [By Ethan Ryder]

  Federated Investors Inc. PA increased its holdings in Littelfuse, Inc. (NASDAQ:LFUS) by 3.9% during the 1st quarter, Holdings Channel reports. The firm owned 9,721 shares of the technology company’s stock after buying an additional 367 shares during the period. Federated Investors Inc. PA’s holdings in Littelfuse were worth $2,024,000 at the end of the most recent quarter.

• [By Joseph Griffin]

  Littelfuse, Inc. (NASDAQ:LFUS) – Research analysts at Barrington Research reduced their Q3 2019 earnings estimates for Littelfuse in a research note issued to investors on Thursday, January 31st. Barrington Research analyst G. Prestopino now forecasts that the technology company will post earnings per share of $2.76 for the quarter, down from their prior forecast of $2.81. Barrington Research has a “Hold” rating on the stock. Barrington Research also issued estimates for Littelfuse’s Q4 2019 earnings at $2.35 EPS, Q2 2020 earnings at $2.91 EPS and FY2020 earnings at $10.63 EPS.

• [By Stephan Byrd]

  KAMES CAPITAL plc lessened its holdings in Littelfuse, Inc. (NASDAQ:LFUS) by 0.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 315,223 shares of the technology company’s stock after selling 2,678 shares during the period. Littelfuse comprises approximately 1.5% of KAMES CAPITAL plc’s portfolio, making the stock its 27th biggest position. KAMES CAPITAL plc owned about 1.26% of Littelfuse worth $62,373,000 at the end of the most recent quarter.

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Littelfuse (LFUS)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Heal Care Stocks To Own For 2019

tags:APB,EPR,AGX,TTWO,SAND ,BXS,BKHU,ASML,MOV,IYM, General Electric's power problems just got worse, and the iconic company's comeback efforts now look even more precarious.

GE Power, the most troubled part of the slumping conglomerate, confirmed on Thursday that one of its gas turbines recently suffered a glitch at a Texas power plant.

The failure was serious enough that Exelon (EXC) said it shut down the power plant -- and as a precaution it also shut another plant that runs on the same GE turbine.

Worse, the problem involves GE's (GE) HA-class turbine, a fast-selling product that the company had been relying on to turn the power division around.

GE said in a statement that it expects the "same issue" to impact other HA units. That suggests GE could be on the hook for significant costs at a time when it's strapped for cash. GE has received orders for more than 80 HA turbines -- and 30 are already in service.

The developments spooked Wall Street, driving GE shares down 3% to $12.45. The stock, which was recently booted from the exclusive Dow Jones Industrial Average, has lost 60% of its value since the end of 2016. News of the turbine outage was earlier reported by Reuters.

Top 10 Heal Care Stocks To Own For 2019: Asia Pacific Fund, Inc. (APB)

Advisors' Opinion:

• [By Logan Wallace]

  Media coverage about Asia Pacific Fund, Inc. (The) common stock (NYSE:APB) has been trending somewhat positive on Sunday, Accern reports. Accern rates the sentiment of press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Asia Pacific Fund, Inc. (The) common stock earned a news impact score of 0.10 on Accern’s scale. Accern also assigned news stories about the investment management company an impact score of 45.8681605197346 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top 10 Heal Care Stocks To Own For 2019: EPR Properties(EPR)

Advisors' Opinion:

• [By Matthew Frankel, CFP, Neha Chamaria, and Matthew DiLallo]

  Who says you can't have high dividends and long-term growth? If you're looking for steady income but aren't willing to sacrifice long-term upside potential, our contributors think EPR Properties (NYSE:EPR), Welltower (NYSE:WELL), and Brookfield Property Partners (NASDAQ:BPY) are worthy of a closer look.

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on EPR Properties (EPR)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on EPR Properties (EPR)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Heal Care Stocks To Own For 2019: Argan, Inc.(AGX)

Advisors' Opinion:

• [By Max Byerly]

  Federated Investors Inc. PA raised its position in Argan, Inc. (NYSE:AGX) by 26.6% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 99,678 shares of the construction company’s stock after buying an additional 20,936 shares during the period. Federated Investors Inc. PA’s holdings in Argan were worth $4,282,000 as of its most recent filing with the SEC.

• [By Logan Wallace]

  Media stories about Argan (NYSE:AGX) have been trending somewhat positive recently, according to Accern Sentiment. The research firm ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Argan earned a daily sentiment score of 0.24 on Accern’s scale. Accern also assigned news stories about the construction company an impact score of 45.7492523122329 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

• [By Joseph Griffin]

  State Board of Administration of Florida Retirement System decreased its holdings in Argan, Inc. (NYSE:AGX) by 26.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,343 shares of the construction company’s stock after selling 1,907 shares during the quarter. State Board of Administration of Florida Retirement System’s holdings in Argan were worth $229,000 at the end of the most recent reporting period.

Top 10 Heal Care Stocks To Own For 2019: Take-Two Interactive Software, Inc.(TTWO)

Advisors' Opinion:

• [By Danny Vena]

  Expectations were high going into video game publisher Take-Two Interactive Software's (NASDAQ:TTWO) earnings report. The results smashed both expectations and the company's guidance, driven by the record-breaking launch of the long-awaited sequel to Red Dead Redemption. The company even increased its full-year outlook based on the strength of the quarter. In situations like that, investors would normally be cheering, but the stock fell more than 14% in the wake of the company's earnings.

• [By Shane Hupp]

  Renaissance Technologies LLC boosted its holdings in shares of TAKE-TWO INTERACTIVE SOFTWARE, INC (NASDAQ:TTWO) by 720.1% in the 2nd quarter, Holdings Channel reports. The firm owned 221,850 shares of the company’s stock after buying an additional 194,800 shares during the period. Renaissance Technologies LLC’s holdings in TAKE-TWO INTERACTIVE SOFTWARE were worth $26,258,000 at the end of the most recent reporting period.

• [By ]

  Wednesday sees earnings from Macy's (M) , Take-Two Interactive (TTWO) and Cisco Systems (CSCO) and Cramer has positive things to say about all three companies.

• [By John Ballard]

  EA is delaying the release of Battlefield V from October to November to allow developers more time to work on it. This is a routine practice in the industry and makes for a much better scenario than releasing an unfinished game that is not ready for prime time, leading to potentially poor reviews (and sales) as a consequence. Take-Two Interactive (NASDAQ:TTWO) has delayed its highly anticipated Red Dead Redemption 2 a few times over the last few years for the same reason. 

Top 10 Heal Care Stocks To Own For 2019: Sandstorm Gold Ltd(SAND )

Advisors' Opinion:

• [By Joseph Griffin]

  Boston Partners purchased a new stake in Sandstorm Gold (NYSEAMERICAN:SAND) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 463,325 shares of the mining company’s stock, valued at approximately $2,205,000. Boston Partners owned about 0.25% of Sandstorm Gold as of its most recent filing with the Securities and Exchange Commission.

• [By Ethan Ryder]

  Sandstorm Gold (NYSEAMERICAN:SAND) had its target price raised by analysts at Raymond James from $5.75 to $6.00 in a research report issued to clients and investors on Thursday. The brokerage currently has an “outperform” rating on the mining company’s stock. Raymond James’ price target points to a potential upside of 4.35% from the stock’s current price.

Top 10 Heal Care Stocks To Own For 2019: BancorpSouth, Inc.(BXS)

Advisors' Opinion:

• [By Stephan Byrd]

  Here are some of the news headlines that may have impacted Accern Sentiment’s rankings:

  Get BancorpSouth Bank alerts: Zacks: Brokerages Anticipate BancorpSouth Bank (BXS) Will Announce Quarterly Sales of $215.14 Million (americanbankingnews.com) BancorpSouth opens on Eldorado Parkway in McKinney (communityimpact.com) Analysts Anticipate BancorpSouth Bank (BXS) to Announce $0.55 EPS (americanbankingnews.com) BancorpSouth Bank (BXS) Given Average Recommendation of “Hold” by Analysts (americanbankingnews.com)

  BXS has been the subject of several research analyst reports. Zacks Investment Research downgraded shares of BancorpSouth Bank from a “hold” rating to a “sell” rating in a research note on Tuesday, March 27th. Hovde Group set a $35.00 price target on shares of BancorpSouth Bank and gave the company a “hold” rating in a research note on Monday, April 23rd. Piper Jaffray set a $36.00 price target on shares of BancorpSouth Bank and gave the company a “hold” rating in a research note on Monday, April 23rd. Royal Bank of Canada reaffirmed a “hold” rating and issued a $37.00 price target on shares of BancorpSouth Bank in a research note on Friday, April 20th. Finally, Brean Capital reaffirmed a “hold” rating on shares of BancorpSouth Bank in a research note on Thursday, January 25th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $35.00.

• [By Max Byerly]

  Get a free copy of the Zacks research report on Bancorpsouth Bank (BXS)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Joseph Griffin]

  Bancorpsouth Bank (NYSE:BXS)‘s stock had its “hold” rating reiterated by Brean Capital in a research note issued to investors on Monday.

• [By Max Byerly]

  QCR (NASDAQ: QCRH) and Bancorpsouth Bank (NYSE:BXS) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Bancorpsouth Bank (BXS)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Heal Care Stocks To Own For 2019: Black Hills Corporation(BKHU)

Advisors' Opinion:

• [By Stephan Byrd]

  Media headlines about BLACK HILLS Cor/EQUITY Ut (NYSE:BKHU) have trended positive recently, Accern reports. The research firm identifies positive and negative news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. BLACK HILLS Cor/EQUITY Ut earned a daily sentiment score of 0.30 on Accern’s scale. Accern also assigned media stories about the company an impact score of 44.7211950698084 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Top 10 Heal Care Stocks To Own For 2019: ASML Holding N.V.(ASML)

Advisors' Opinion:

• [By Max Byerly]

  Get a free copy of the Zacks research report on ASML (ASML)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Shane Hupp]

  ASML (NASDAQ:ASML)‘s stock had its “sell” rating reiterated by research analysts at DZ Bank in a note issued to investors on Friday.

• [By Ethan Ryder]

  Royal Bank of Canada reaffirmed their buy rating on shares of ASML (NASDAQ:ASML) in a research note issued to investors on Friday morning.

  A number of other research firms have also commented on ASML. BidaskClub upgraded shares of ASML from a buy rating to a strong-buy rating in a research report on Friday, March 9th. Santander lowered shares of ASML from a buy rating to a hold rating in a research report on Monday, March 19th. Zacks Investment Research lowered shares of ASML from a strong-buy rating to a hold rating in a research report on Tuesday, March 20th. ValuEngine upgraded shares of ASML from a hold rating to a buy rating in a research report on Monday, April 2nd. Finally, Cowen began coverage on shares of ASML in a research report on Monday, May 14th. They issued a market perform rating for the company. Four analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. ASML presently has a consensus rating of Buy and a consensus target price of $199.86.

• [By Shane Hupp]

  Goldman Sachs Group set a €221.00 ($256.98) price target on ASML (EPA:ASML) in a report published on Friday. The firm currently has a buy rating on the stock.

Top 10 Heal Care Stocks To Own For 2019: Movado Group Inc.(MOV)

Advisors' Opinion:

• [By Lisa Levin]

  Shares of Movado Group, Inc. (NYSE: MOV) got a boost, shooting up 16 percent to $49.00 after the company reported better-than-expected Q1 results and raised its guidance.

• [By Dan Caplinger]

  Wall Street had another summer celebration on Wednesday, as the S&P 500 and Nasdaq Composite once again set records. Most investors attributed the gains to a 4.2% rise in gross domestic product during the second quarter, which was slightly faster than the initial estimate on GDP had suggested last month. Yet even with a favorable attitude prevailing throughout most of the market, some stocks suffered setbacks. Movado Group (NYSE:MOV), Roku (NASDAQ:ROKU), and American Eagle Outfitters (NYSE:AEO) were among the worst performers on the day. Here's why they did so poorly.

• [By Lisa Levin] Gainers Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing. Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study. Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook. Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital. TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy. Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance. ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating. Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011. InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS. Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy.. SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday. Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to
• [By Steve Symington]

  Shares of Movado Group Inc. (NYSE:MOV) were up 16.5% as of 12:30 p.m. EDT Wednesday after the watchmaker announced strong quarterly results.

  For Movado's fiscal first quarter ended April 30, 2018, net sales grew 28.1% year over year (22.1% in constant currency) to $127.1 million, including roughly $2.2 million related to the adoption of new accounting standards. On the bottom line, that translated to adjusted earnings of $8.7 million, or $0.37 per share, up from $0.01 per share in the same year-ago period.

Top 10 Heal Care Stocks To Own For 2019: iShares US Basic Materials (IYM)

Advisors' Opinion:

• [By Jim Crumly]

  Technology stocks led the market, with Apple making history by being the first U.S. company to break through $1 trillion in market capitalization. The Technology Select Sector SPDR ETF (NYSEMKT:XLK) gained 1.3%. The materials sector lagged; the iShares US Basic Materials ETF (NYSEMKT:IYM) fell 1%.

• [By Jim Crumly]

  Materials and consumer stocks led the way; iShares US Basic Materials ETF (NYSEMKT:IYM) rose 2.2% and the Consumer Discretionary Select SPDR ETF (NYSEMKT:XLY) gained 1.5%.